ZTS

SELL

Zoetis Inc.

Healthcare · Rank #204 · Analyzed Apr 20, 2026

$122.38

Current Price

$69.65

Intrinsic Value

-27.2%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 27.2%

Fair Value Range

Low$6.34

Base (IV)$69.65

High$89.10

Entry Points

Conservative$6.34

Moderate$37.99

Aggressive$69.65

Quality & Moat Breakdown

Return on Equity66.0% → 1.0/1.0

Debt LevelD/E 280 → 0/1.0

Revenue QualityGrowth -2.4%, margin Δ+18.2% → 0/1.0

Moat Strength3.5/5 → 0.5/1.0

Profit Margins28.2% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.